文献速递儿童呼吸儿童感染

不同病原儿童肺炎气道黏液高分泌的临床特征与危险因素

[Clinical characteristics and risk factors for bronchoscopic airway mucus hypersecretion in childhood pneumonia infected by different pathogens].
PubMed 文献 · Zhonghua Er Ke Za Zhi · 2023-01-01

该回顾性队列纳入968例因肺炎支原体肺炎、呼吸道合胞病毒肺炎或腺病毒肺炎住院并接受支气管镜检查的患儿,按镜下黏液分泌评分分为高分泌组与非高分泌组。研究发现三种病原感染患儿高分泌组就诊年龄均大于非高分泌组,并分别识别出外周血白细胞、中性粒细胞、淋巴细胞、白蛋白、嗜酸粒细胞及肺部听诊啰音等与气道黏液高分泌相关的因素。

要点

  • 三种病原肺炎患儿中,气道黏液高分泌组就诊年龄均大于非高分泌组。
  • MPP患儿外周血白细胞升高、中性粒细胞比例升高、淋巴细胞计数降低、白蛋白降低与黏液高分泌风险增加相关。
  • RSV肺炎患儿外周血嗜酸粒细胞升高及重症肺炎与黏液高分泌相关;腺病毒肺炎患儿年龄较大及闻及啰音、哮鸣音或痰鸣音与黏液高分泌相关。

核心结论

  • MPP患儿外周血白细胞计数升高、中性粒细胞比例升高、淋巴细胞计数降低及血清白蛋白降低与气道黏液高分泌相关。
  • RSV肺炎患儿外周血嗜酸粒细胞异常升高与气道黏液高分泌相关,且气道黏液高分泌与重症肺炎相关。
  • 腺病毒肺炎患儿年龄较大及肺部闻及啰音、哮鸣音或痰鸣音与气道黏液高分泌相关。
  • 呼吸道局部中性粒细胞浸润与肺炎支原体和RSV感染的气道黏液高分泌发生密切相关。

研究设计与样本

  • 回顾性队列研究,纳入2019年1月至2021年12月在重庆医科大学附属儿童医院呼吸科因MPP、RSV肺炎、腺病毒肺炎住院并行支气管镜检查的968例患儿。
  • 按支气管镜下黏液分泌评分分为气道黏液高分泌组和非高分泌组,比较两组人口学特征、临床特征、实验室检查及疾病严重度。
  • 采用χ2检验、Mann-Whithey U检验、Fisher确切概率法分析组间差异,多因素Logistic回归分析影响因素。

主要发现

  • 968例患儿中男559例、女409例,就诊年龄4.0(1.4,6.0)岁;MPP 642例(高分泌组185例、非高分泌组457例),RSV肺炎201例(高分泌组41例、非高分泌组160例),腺病毒肺炎125例(高分泌组39例、非高分泌组86例)。
  • MPP、RSV、腺病毒肺炎患儿高分泌组就诊年龄均大于非高分泌组,分别为6.0(4.0,7.0)比5.0(3.0,7.0)岁、1.5(0.5,3.6)比0.8(0.4,1.6)岁、2.0(1.2,4.5)比1.3(0.8,2.0)岁,U=35 295.00、2 492.00、1 101.00,均P<0.05。
  • MPP患儿高分泌组BALF中性粒细胞比例高于非高分泌组(0.65(0.43,0.81)比0.59(0.34,0.76),U=24 507.00,P<0.01),BALF巨噬细胞比例低于非高分泌组(0.10(0.05,0.20)比0.12(0.06,0.24),U=33 043.00,P<0.05)。
  • RSV肺炎患儿高分泌组BALF有核细胞计数及中性粒细胞比例均高于非高分泌组(1 210(442,2 100)×106比490(210,1 510)×106/L、0.43(0.26,0.62)比0.30(0.13,0.52),U=2 043.00、2 064.00,均P<0.05)。

关键数值与推荐

  • MPP患儿外周血白细胞计数升高(OR=3.30,95%CI 1.51~7.93,P=0.004)、中性粒细胞比例升高(OR=2.24,95%CI 1.16~4.33,P=0.016)、淋巴细胞计数降低(OR=3.22,95%CI 1.66~6.31,P<0.001)、血清白蛋白降低(OR=2.00,95%CI 1.01~3.98,P=0.047)与气道黏液高分泌风险增加相关。
  • RSV肺炎患儿外周血嗜酸粒细胞升高(OR=3.04,95%CI 1.02~8.93,P=0.043)与气道黏液高分泌风险增加相关,气道黏液高分泌与重症肺炎相关(OR=2.46,95%CI 1.03~6.15,P=0.047)。
  • 腺病毒肺炎患儿年龄较大(OR=1.02,95%CI 1.00~1.04,P=0.026)、肺部听诊闻及啰音、哮鸣音或痰鸣音(OR=3.65,95%CI 1.22~12.64,P=0.028)与气道黏液高分泌风险增加相关。

临床怎么用

  • 对MPP患儿可关注外周血白细胞计数、中性粒细胞比例、淋巴细胞计数及血清白蛋白水平,以识别气道黏液高分泌风险较高的患儿。
  • 对RSV肺炎患儿可关注外周血嗜酸粒细胞水平及重症肺炎情况;对腺病毒肺炎患儿可关注年龄及肺部啰音、哮鸣音或痰鸣音。
  • 支气管肺泡灌洗液中性粒细胞浸润情况与MPP及RSV肺炎气道黏液高分泌相关,可作为临床评估参考。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Objective: To investigate the risk factors for airway mucus hypersecretion in childhood pneumonia infected by different pathogens. Method: A retrospective cohort included 968 children who were hospitalized for Mycoplasma pneumoniae pneumonia (MPP), respiratory syncytial virus (RSV) pneumonia, adenovirus pneumonia and underwent bronchoscopy in Respiratory Department of Children's Hospital of Chongqing Medical University from January 2019 to December 2021 was conducted. The children were divided into two groups distinguished by airway mucus secretion according to the airway mucus hypersecretion score which were scored according to the mucus secretion under the bronchoscope. The demographic characteristics, clinical characteristics, laboratory tests and disease severity of the two groups were compared. And the risk factors for the development of airway mucus hypersecretion in two groups were analyzed. Chi square test, Mann-Whithey U test and Fisher exact test were used to analyze the differences between the two groups, and multivariate Logistic regression was used to analyze the influencing factors. Result: There were 559 males and 409 females in the 968 children, with an age of 4.0 (1.4, 6.0) years. Among the 642 children with MPP, 185 cases were in the hypersecretion group and 457 cases were in the non-hypersecretion group. There were 41 cases in the hypersecretion group and 160 cases in the non-hypersecretion group of 201 children with RSV pneumonia. In the 125 children with adenovirus pneumonia, there were 39 cases in the hypersecretion group and 86 cases in the non-hypersecretion group. In these children, the age of children in the hypersecretion group was older than that in the non-hypersecretion group (6.0 (4.0, 7.0) vs. 5.0 (3.0, 7.0) years old, 1.5 (0.5, 3.6) vs. 0.8 (0.4, 1.6) years old, 2.0 (1.2, 4.5) vs. 1.3 (0.8, 2.0) years old, U=35 295.00, 2 492.00, 1 101.00, all P<0.05). Through multivariate Logistic regression analysis it found that increased risk of airway mucus hypersecretion was present in childhood MPP with increase in peripheral blood white blood cell count (OR=3.30, 95%CI 1.51-7.93, P=0.004) or increase in neutrophil ratio (OR=2.24, 95%CI 1.16-4.33, P=0.016) or decrease in lymphocyte count (OR=3.22, 95%CI 1.66-6.31, P<0.001) or decrease in serum albumin (OR=2.00, 95%CI 1.01-3.98, P=0.047). The risk of airway mucus hypersecretion was increased in children with RSV pneumonia combined with elevated peripheral blood eosinophils (OR=3.04, 95%CI 1.02-8.93, P=0.043). Meanwhile, airway mucus hypersecretion was associated with severe pneumonia (OR=2.46, 95%CI 1.03-6.15, P=0.047) in children with RSV pneumonia. Older age was associated with increased risk of airway mucus hypersecretion in children with adenovirus pneumonia (OR=1.02, 95%CI 1.00-1.04, P=0.026). In these children with occurrence of pulmonary rales, wheezes or sputum sounds (OR=3.65, 95%CI 1.22-12.64, P=0.028) had an increased risk of airway mucus hypersecretion. Neutrophils in bronchoalveolar lavage fluid (BALF) demonstrated higher ratio in hypersecretion group from children with MPP (0.65 (0.43, 0.81) vs. 0.59 (0.34, 0.76), U=24 507.00, P<0.01), while the proportion of macrophages in BALF was lower (0.10 (0.05, 0.20) vs. 0.12 (0.06, 0.24), U=33 043.00, P<0.05). Nucleated cell count and neutrophil ratio in BALF were higher in hypersecretion group of children with RSV pneumonia (1 210 (442, 2 100)×106 vs. 490 (210, 1 510)×106/L, 0.43 (0.26, 0.62) vs. 0.30 (0.13, 0.52), U=2 043.00, 2 064.00, all P<0.05). Conclusions: The increase in peripheral blood white blood cell count, neutrophil ratio and decrease in lymphocyte count, serum albumin in children with MPP is related to the development of airway mucus hypersecretion. In children with RSV pneumonia, the abnormal increase of eosinophils in peripheral blood has relationship with hypersecretion. The appearance of lung rale, wheezing, and sputum rale are associated with airway mucus hypersecretion in children with adenovirus pneumonia. In addition, local neutrophil infiltration in the respiratory tract is closely related to the occurrence of airway mucus hypersecretion caused by Mycoplasma pneumoniae and RSV infection. 目的: 探讨不同病原感染的肺炎患儿发生气道黏液高分泌状态的危险因素。 方法: 回顾性队列研究。收集2019年1月至2021年12月在重庆医科大学附属儿童医院呼吸科因肺炎支原体肺炎(MPP)、呼吸道合胞病毒(RSV)肺炎、腺病毒肺炎住院并行支气管镜检查的968例患儿临床资料。对支气管镜下黏液分泌情况进行评分,并分为气道黏液高分泌组和非高分泌组,分别比较3种病原感染肺炎患儿两组的人口学特征、临床特征、实验室检查、疾病严重度,分析其发生气道黏液高分泌状态的危险因素。应用χ2检验、Mann-Whithey U检验、Fisher确切概率法分析组间差异,多因素Logistic回归分析影响因素。 结果: 968例患儿中男559例、女409例,就诊年龄4.0(1.4,6.0)岁。642例MPP患儿中高分泌组185例、非高分泌组457例;201例RSV肺炎患儿中高分泌组41例、非高分泌组160例;125例腺病毒肺炎患儿中高分泌组39例、非高分泌组86例。MPP、RSV、腺病毒3种病原感染的肺炎患儿高分泌组就诊年龄均大于非高分泌组[6.0(4.0,7.0)比5.0(3.0,7.0)岁、1.5(0.5,3.6)比0.8(0.4,1.6)岁、2.0(1.2,4.5)比1.3(0.8,2.0)岁,U=35 295.00、2 492.00、1 101.00,均P<0.05]。多因素Logistic回归分析显示,外周血白细胞计数升高(OR=3.30,95%CI 1.51~7.93,P=0.004)、中性粒细胞比例升高(OR=2.24,95%CI 1.16~4.33,P=0.016)、淋巴细胞计数降低(OR=3.22,95%CI 1.66~6.31,P<0.001)、血清白蛋白降低(OR=2.00,95%CI 1.01~3.98,P=0.047)的MPP患儿发生气道黏液高分泌的风险增加;外周血嗜酸粒细胞升高(OR=3.04,95%CI 1.02~8.93,P=0.043)的RSV肺炎患儿发生气道黏液高分泌的风险增加,气道黏液高分泌与重症肺炎相关(OR=2.46,95%CI 1.03~6.15,P=0.047);年龄较大(OR=1.02,95%CI 1.00~1.04,P=0.026)、肺部听诊闻及啰音、哮鸣音或痰鸣音(OR=3.65,95%CI 1.22~12.64,P=0.028)的腺病毒肺炎患儿发生气道黏液高分泌的风险均增加。MPP患儿中高分泌组支气管肺泡灌洗液(BALF)中性粒细胞比例高于非高分泌组[0.65(0.43,0.81)比0.59(0.34,0.76),U=24 507.00,P<0.01],BALF巨噬细胞比例低于非高分泌组[0.10(0.05,0.20)比0.12(0.06,0.24),U=33 043.00,P<0.05];RSV肺炎患儿高分泌组BALF有核细胞计数及中性粒细胞比例均高于非高分泌组[1 210(442,2 100)×106比490(210,1 510)×106/L、0.43(0.26,0.62)比0.30(0.13,0.52),U=2 043.00、2 064.00,均P<0.05]。 结论: MPP患儿的外周血白细胞计数升高、中性粒细胞比例升高、淋巴细胞计数降低以及白蛋白降低均与气道黏液高分泌有关,RSV肺炎患儿外周血嗜酸粒细胞异常升高与气道黏液高分泌相关,腺病毒肺炎患儿肺部啰音、哮鸣音、痰鸣音的出现与气道黏液高分泌相关。呼吸道局部中性粒细胞浸润与肺炎支原体和RSV感染的气道黏液高分泌的发生密切相关。.

来源:Zhonghua Er Ke Za Zhi,查看原文。版权归原作者所有。

引用

  1. Cai JY, Yan CY, Wang XQ, et al. [Clinical characteristics and risk factors for bronchoscopic airway mucus hypersecretion in childhood pneumonia infected by different pathogens]. Zhonghua Er Ke Za Zhi. 2023. PMID: 37528013. doi:10.3760/cma.j.cn112140-20230315-00184

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。